锦欣生殖医疗集团有限公司（01951）于2026年4月10日公告回购3,200,000股普通股，占已发行股本约0.12%。回购价格区间为每股2.44港元至2.47港元，合计支付金额7,888,960港元，约合788.90万港元。
回购完成后，公司已发行股本仍为2,705,044,043股，库藏股数量为0股。该回购基于2025年6月26日通过的购回授权，公司可回购最多274,470,604股股份，迄今已合计回购49,168,000股。公司确认遵守香港联合交易所有限公司证券上市规则及相关法规。公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.